Bessemer Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Bessemer Group’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1	Closed	–	–	2331
2023 Q3	$0	Buy	+1	New	–	﹤0.01%	2403
2021 Q1	–	Sell	-267	Closed	-$10K	–	1695
2020 Q4	$10K	Sell	267 -66	-20%	-$2.39K	﹤0.01%	1297
2020 Q3	$12K	Sell	333 -5,267	-94%	-$229K	﹤0.01%	1109
2020 Q2	$238K	Buy	+5,600	New	+$377K	﹤0.01%	1122

Bessemer Group's EVFM Position: Q4 2023 in Review

Bessemer Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2023, closing a stake of 1 share.

Bessemer Group first reported a position in EVFM in Q2 2020 and held it in 4 quarters. The position peaked at $238K in Q2 2020. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2023.

Bessemer Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bessemer Group sold 1 Evofem Biosciences, Inc. Common Stock share in Q4 2023.
Bessemer Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Bessemer Group's Evofem Biosciences, Inc. Common Stock position peaked at $238K in Q2 2020.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2023.

Based on Bessemer Group's 13F filing for Q4 2023, filed 9 Feb 2024.